Finance

Lists
GBLX:OTCMKTS
GB Sciences Inc
0,00010 $
0,00%
(0,00) 1D
16 қаз., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GBLX...
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
40,71 мың
Avg. vol.
39,58 мың
Volume
16,56 мың
52-wk high
0,50 $
52-wk low
0,00 $
Beta
1,61
Shares outstanding
407,07 млн
No. of employees
2
Open
0,00 $
High
0,00 $
Low
0,00 $
Mkt. cap
40,71 мың
Avg. vol.
39,58 мың
Volume
16,56 мың
52-wk high
0,50 $
52-wk low
0,00 $
Beta
1,61
Shares outstanding
407,07 млн
No. of employees
2
News stories
From web sources and news partners
About GB Sciences Inc
CEO-
Employees2
Founded2001 ж. 04 сәу.
HeadquartersЛас Вегас, Невада, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitegbsciences.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024 ж. қыр.
2024 ж. жел.
Revenue
-
97,24 мың
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
157,79 м.
163,83 м.
Operating expense
157,79 м.
163,83 м.
Total operating expenses
157,79 м.
163,83 м.
Operating income
-157,79 м.
-66,59 мың
Other non operating income
-
-
EBT including unusual items
-190,53 м.
-100,36 м.
EBT excluding unusual items
-190,53 м.
-100,36 м.
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-190,53 м.
-100,36 м.
Net profit margin
-
-103,21%
Earnings per share
-
-
Interest and investment income
-
-
Interest expense
-32,74 мың
-33,76 мың
Net interest expenses
-32,74 мың
-33,76 мың
Depreciation and amortization charges
-
-
EBITDA
-157,63 м.
-66,44 мың
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары